Crystalys
Company Details
Status: Private
Employees: 11-50
Location:
San Diego, California, United States
Type:
sample
Technology:
sample
About: Crystalys is a clinical-stage biopharmaceutical company transforming the treatment of gout. Co-founded by Novo Holdings and Catalys Pacific, Crystalys brings together a world-class team with deep expertise in gout drug development, dedicated to delivering more effective options for people living with gout.
Dotinurad, the company’s lead candidate and next-generation URAT1 inhibitor with best-in-class potential for safety and efficacy, is being advanced into global Phase 3 trials as a second-line therapy for gout, supported by extensive clinical data from approvals in multiple Asian markets.
Unlock access to company contacts, hot leads, and drug pipelines.
Log in or create a free account now!
Crystalys | Active clinical trials on ClinicalTrials.gov
Active Clinical Trials Count | 0
No Active Trials Found On ClinicalTrials.gov.